Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Grasso, Catherine S, Tang, Yujie, Truffaux, Nathalene, Berlow, Noah E, Liu, Lining, Debily, Marie-Anne, Quist, Michael J, Davis, Lara E +32 more·2015·Nature Medicine
DOI 10.1038/nm.3855

Cited by (686)

Items 401–500 of 686

  1. The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities
    Wafik Tharwat Zaky, Christa A. Manton, Claudia P. Miller, Soumen Khatua, Vidya Gopalakrishnan, Joya Chandra · 2017 · Cancer and Metastasis Reviews
  2. Increasing value of autopsies in patients with brain tumors in the molecular era
    Jared T. Ahrendsen, Mariella G. Filbin, Susan N Chi, Peter E. Manley, Karen D. Wright, Pratiti Bandopadhayay, Jessica R. Clymer, Kee Kiat Yeo, Mark W. Kieran, Robert E. Jones et al. · 2019 · Journal of Neuro-Oncology
  3. Posterior Fossa and Brainstem Tumors in Children
    Saira B. Alli, Semra Işık, James T. Rutka · 2018 · Elsevier eBooks
  4. Targeting the epigenome of cancer stem cells in pediatric nervous system tumors
    Natália Hogetop Freire, Mariane da Cunha Jaeger, Caroline Brunetto de Farias, Carolina Nör, Bárbara Kunzler Souza, Lauro José Gregianin, Andre Tesainer Brunetto, Rafael Roesler · 2023 · Molecular and Cellular Biochemistry
  5. Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas
    Anahid Ehteda, Aaminah Khan, Gayathiri Rajakumar, Anne S. Vanniasinghe, Anjana Gopalakrishnan, Jie Liu, Maria Tsoli, David Simon Ziegler · 2023 · Molecular Cancer Therapeutics
  6. Advances in the biology and treatment of pediatric central nervous system tumors
    Nicholas Alexander Vitanza, Yoon‐Jae Cho · 2015 · Current Opinion in Pediatrics
  7. Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review)
    Jorge B. Scutti · 2018 · International Journal of Oncology
  8. Pediatric high-grade glioma: a review of biology, prognosis, and treatment
    Abhishek Amar Bavle, Murali Chintagumpala · 2018 · Journal of Radiation Oncology
  9. Epigenetic-Targeted Treatments for H3K27M-Mutant Midline Gliomas
    Victor M. Lu, David J. Daniels · 2020 · Advances in experimental medicine and biology
  10. A Protocol for the Generation of Treatment-naïve Biopsyderived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models
    Matthew C. Biery, Alyssa Noll, Carrie H. Myers, Shelli M. Morris, Conrad Winter, Fiona J. Pakiam, Bonnie Cole, Samuel R. Browd, James M. Olson, Nicholas Alexander Vitanza · 2020 · Journal of Experimental Neurology
  11. Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide
    Takeyoshi Eda, Masayasu Okada, Ryosuke Ogura, Yoshihiro Tsukamoto, Yu Kanemaru, Jun Watanabe, Jotaro On, Hiroshi Aoki, Makoto Oishi, Nobuyuki Takei et al. · 2022 · Cancers
  12. Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas
    Nikolaus von Knebel Doeberitz, Daniel Paech, Dominik Sturm, Stefan Pusch, Şevin Turcan, Yogen Saunthararajah · 2022 · International Journal of Cancer
  13. Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors
    Sydney T. Grob, Jean M. Mulcahy Levy · 2017 · Molecular Diagnosis & Therapy
  14. Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management
    Bo Pang, Songyuan An, Yun Liu, Tao Jiang, Wenqing Jia, Ruichao Chai, Yongzhi Wang · 2024 · Cancer Letters
  15. Cytotoxicity of nonylphenol on spermatogonial stem cells via phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin pathway
    Junhao Lei, Wen Yan, Chunhua Luo, Yu-Ming Guo, Yang-Yang Zhang, Xinghuan Wang, Xinjun Su · 2020 · World Journal of Stem Cells
  16. H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics
    Julian S. Rechberger, Blake T. Power, Erica A. Power, Cody L. Nesvick, David J. Daniels · 2023 · Expert Opinion on Therapeutic Targets
  17. Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass
    Tiziana Servidei, Alessandro Sgambato, Donatella Lucchetti, Pierluigi Navarra, Antonio Ruggiero · 2023 · Frontiers in Bioscience-Landmark
  18. Phase I Study of Vorinostat and Temsirolimus in Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
    Lea M. Stitzlein, Muhammad Usman Baig, Joya Chandra, Suzanne McGovern, Arnold C. Paulino, Leena Ketonen, Soumen Khatua, Wafik Tharwat Zaky · 2025 · Pediatric Blood & Cancer
  19. Targeting Epigenetic Dependencies in Solid Tumors: Evolutionary Landscape Beyond Germ Layers Origin
    Francesca Citron, Linda Fabris · 2020 · Cancers
  20. Post‐mortem tissue donation programs as platforms to accelerate cancer research
    Matthew Dankner, Badia Issa‐Chergui, Nathaniel Bouganim · 2020 · The Journal of Pathology Clinical Research
  21. Characterization of Diffuse Intrinsic Pontine Glioma Radiosensitivity using Synchrotron Microbeam Radiotherapy and Conventional Radiation Therapy In Vitro
    Lloyd M. L. Smyth, Peter A. W. Rogers, Jeffrey C Crosbie, Jacqueline F. Donoghue · 2017 · Radiation Research
  22. Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG
    Diana M. Carvalho, Sara Temelso, Alan G. Mackay, Helen N. Pemberton, Rebecca F. Rogers, Ketty Kessler, Elisa Izquierdo, Lynn M. Bjerke, Janat Fazal Salom, Matthew Clarke et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas
    Danielle Algranati, R. Oren, B. Dassa, Liat Fellus-Alyagor, A. Plotnikov, H. Barr, A. Harmelin, N. London, Guy Ron, Noa Furth et al. · 2024 · bioRxiv
  24. The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models
    Liam M. Furst, Enola Roussel, Ryan F. Leung, Ankita M. George, Sarah A. Best, James Richard Whittle, Ron Firestein, Maree C. Faux, David D. Eisenstat · 2024 · Biology
  25. Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG
    Yuxuan Deng, Jinqiu Liu, Zhuonan Pu, Yi Wang, Tian Li, Zhuang Jiang, L Z Xie, Xiaoli Zhang, Yi Chen, Mingxu Yang et al. · 2025 · Journal of Experimental & Clinical Cancer Research
  26. Current Landscape of Preclinical Models for Pediatric Gliomas: Clinical Implications and Future Directions
    Syed Mohd Faisal, Monika Yadav, Garrett R. Gibson, Adora T. Klinestiver, Ryan M. Sorenson, Evan Cantor, Maria Ghishan, John R. Prensner, Andrea T. Franson, Kevin Fate Ginn et al. · 2025 · Cancers
  27. Multicellular tumor-stromal interactions recapitulate aspects of therapeutic response and human oncogenic signaling in a 3D disease model for H3K27M-altered DIPG
    Meenakshi Upreti, Astgik Petrosyan, Matthew Edward Thornton, Anahit Hovsepyan, G. Esteban Fernández, David S. Koos, Stephanie D. Byrum, Samuel G. Mackintosh, Jacob K. Al-Husseini, Tania Bibiana Porras et al. · 2025 · Oncogene
  28. Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states
    Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, Junqiang Wang, Aleksandar Obradović, Pasquale Laise, Aaron Timothy Griffin, Lukas J. Vlahos, Hanna E. Minns, Diana V. Morales et al. · 2026 · Nature Genetics
  29. Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
    Markus Bredel, Lluı́s Espinosa, Hyunsoo Kim, Denise M. Scholtens, Joseph Paul McElroy, Rajani Rajbhandari, Wei Meng, Thomas M. Kollmeyer, Tathiane Maistro Malta, Michael A. Quezada et al. · 2023 · Cell Reports Medicine
  30. Efficacy of convection enhanced delivery of MTX110 (soluble panobinostat) in preclinical Diffuse Intrinsic Pontine Glioma models using metabolic hyperpolarized 13C imaging
    Justyna Magdalena Przystal, Ilwoo Park, Jie Zhang, Piotr Hadaczek, Krystof S. Bankiewicz, Nalin M. Gupta, Javad Nazarian, Sabine Mueller · 2023 · EJC Paediatric Oncology
  31. The Potential Role of Histone Modifications in Glioblastoma Therapy: Review Article
    Mohammed Atef Azab · 2023 · Journal of Molecular Pathology
  32. Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation
    Benjamin I. Siegel, Prabhumallikarjun Patil, Akul Prakash, Darren M. Klawinski, Eugene I. Hwang · 2025 · Frontiers in Oncology
  33. The Epigenetic Regulation of OLIG2 by Histone Demethylase KDM6B in Glioma Cells
    Aixia Sui, Biaogang Han, Wenjun Ren, Weiliang He, Chao Gao, Xiaohui Han, Shifeng Liu, Yan Zhang, Xueling Qi, Xiaoqiang Guo · 2022 · Journal of Molecular Neuroscience
  34. Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights
    Qian Zhou, Yichen Xu, Yan Zhou, Jincheng Wang · 2022 · Molecules
  35. High Intra-Tumor Transforming Growth Factor Beta 2 Level as a Predictor of Poor Treatment Outcomes in Pediatric Diffuse Intrinsic Pontine Glioma
    Fatih Mehmet Uckun, Sanjive Qazi, Vuong N. Trieu · 2023 · Cancers
  36. Clinical trials using molecular stratification of pediatric brain tumors
    Samuel Z. Hanz, Oluwaseyi O. Adeuyan, Grace Lieberman, Tammy Hennika · 2020 · Translational Pediatrics
  37. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma
    Hongnan Cao, Miao Jin, Mu Gao, Hongyi Zhou, Yizhi Jane Tao, Jeffrey Skolnick · 2020 · Scientific Reports
  38. Pediatric Gliomas
    Sophie Peeters, Yagmur Muftuoglu, Brian S Na, David J. Daniels, Anthony Wang · 2021 · Neurosurgery Clinics of North America
  39. Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma
    Zilu Huang, Zhigang Liu, Lin Qi, Yalan Tao, Xinzhuoyun Li, Patricia Ann Baxter, Jack M. F. Su, Adekunle M. Adesina, Chris Man, Murali Chintagumpala et al. · 2024 · Translational Oncology
  40. Modelling brain tumours with organoids: towards precision medicine in neuro-oncology
    Marta de Lucas Sanz, Simone P. Niclou, Anna Golebiewska · 2026 · Nature Reviews Neurology
  41. DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically
    Ashley R Tetens, Allison M. Martin, Antje Arnold, Orlandi Novak, Adrian Idrizi, Rakel Tryggvadóttir, Jordyn Craig-Schwartz, Athanasia Liapodimitri, Kayleigh Lunsford, Michael I. Barbato et al. · 2024 · Neuro-Oncology Advances
  42. The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases
    Arun Kumaran Anguraj Vadivel, Sanja Pajovic, Robert Siddaway, Sabrina Zhu, Stefanie-Grace Sbergio, Olivera Matic, Lauren Phillips, Yong Jia Bu, Mark Nitz, Cynthia E Hawkins · 2025 · Neuro-Oncology
  43. Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant
    Karin Eytan, Ziv Versano, Roni Oren, Jasmine Jacob‐Hirsch, Moshe Leitner, Alon Harmelin, Gideon Rechavi, Amos Toren, Shoshana Paglin, Michal Yalon · 2022 · Frontiers in Oncology
  44. Amphiphilic Poly(2-oxazoline)s with Glycine-Containing Hydrophobic Blocks Tailored for Panobinostat- and Imatinib-Loaded Micelles
    Natalie E. Göppert, Sabina Quader, Joachim F. R. Van Guyse, Christine Weber, Kazunori Kataoka, Ulrich S. Schubert · 2023 · Biomacromolecules
  45. PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo
    Elizabeth J. Brown, Leire Balaguer‐Lluna, Adam P. Cribbs, Martin Philpott, Leticia Campo, Molly Browne, Jong Fu Wong, Udo C. T. Oppermann, Angel Montero Carcaboso, Alex N. Bullock et al. · 2024 · Scientific Reports
  46. Improving long-term survival in diffuse intrinsic pontine glioma
    James T. Felker, Alberto Broniscer · 2020 · Expert Review of Neurotherapeutics
  47. Brain stem gliomas and current landscape
    Brandon M. Wummer, Delaney Woodworth, Catherine Flores · 2021 · Journal of Neuro-Oncology
  48. The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 Mutation
    David Roig-Carles, Holly Jackson, Katie F. Loveson, Alan G. Mackay, Rebecca L. Mather, Ella V. Waters, Massimiliano Manzo, Ilaria Alborelli, Jon P. Golding, Chris Jones et al. · 2021 · International Journal of Molecular Sciences
  49. Dissecting telomere maintenance mechanisms in pediatric glioblastoma
    Katharina I. Deeg, Inn Chung, Alexandra Maria Poos, Delia M. Braun, Andrey Korshunov, Marcus Oswald, Nick Kepper, Sebastian Bender, David Castel, Peter Lichter et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations
    Amber N. Habowski, Deepthi Poornima Budagavi, Sandra D. Scherer, Arin B. Aurora, Giuseppina Caligiuri, William F. Flynn, Ellen M. Langer, Jonathan Robert Brody, Rosalie C. Sears, Giorgia Foggetti et al. · 2024 · Cancers
  51. Safety and Efficacy of Biopsy in Patients with Diffuse Intrinsic Pontine Gliomas
    Aprajita Chaturvedi, Nishanth Sadashiva, Sathyarao Kalahasti, Subhas Kanti Konar, Uday Krishna, Andiperumal Raj Prabhuraj, Dhaval Prem Shukla, Manish Beniwal, Nupur Pruthi, Arivazhagan Arima et al. · 2024 · World Neurosurgery
  52. Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma
    Holly Holliday, Aaminah Khan, Anahid Ehteda, Hieu Nguyen, Samuel E. Ross, Nisitha Jayatilleke, Anjana Gopalakrishnan, Eyden Wang, Yolanda Colino‐Sanguino, Daisy Kavanagh et al. · 2026 · Science Translational Medicine
  53. Diffuse intrinsic pontine gliomas in pediatric patients: management updates
    Caroline Grace Davidson, Samuel Joel Woodford, Daisy Valle, Grace Parker, Ann-Marie Derias, Carina Copley, Brandon Peter Lucke-Wold · 2023 · The Egyptian Journal of Neurosurgery : the official publication of the Egyptian Society of Neurological Surgeons/Egyptian journal of neurosurgery
  54. Targeting ‘histone mark’: Advanced approaches in epigenetic regulation of telomere dynamics in cancer
    Ankita Das, Ashok Kumar Giri, Pritha Bhattacharjee · 2024 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  55. Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas
    Konstantinos Vazaios, Patricia Hernández-López, Tineke Aarts‐Riemens, Annet Daudeij, Vera Kemp, Rob C. Hoeben, Trudy Straetemans, Esther Hulleman, Friso Calkoen, Jasper van der Lugt et al. · 2025 · International Journal of Molecular Sciences
  56. Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time
    Erica A. Power, Julian S. Rechberger, Liang Zhang, Ju‐Hee Oh, Jacob B. Anderson, Cody L. Nesvick, Jizhi Ge, Edward H. Hinchcliffe, William F. Elmquist, David J. Daniels · 2023 · Neuro-Oncology Advances
  57. The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles
    Konstantinos Vazaios, Εftychia Stavrakaki, Lisette B. Vogelezang, Jie Ju, Piotr Waranecki, Dennis Serge Metselaar, Michaël Hananja Meel, Vera Kemp, Bernadette G. van den Hoogen, Rob C. Hoeben et al. · 2024 · Molecular Therapy Oncology
  58. Understanding the epigenetic landscape and cellular architecture of childhood brain tumors
    Gustavo Alencastro Veiga Cruzeiro, Christopher Rota, Olivia A. Hack, Rosalind A. Segal, Mariella G. Filbin · 2020 · Neurochemistry International
  59. Long non-coding RNA LUCAT1 regulates the RAS pathway to promote the proliferation and invasion of malignant glioma cells through ABCB1
    Xia Wu, Lvmeng Song, Xiangrong Chen, Yalan Zhang, Shun Li, Xiaoping Tang · 2022 · Experimental Cell Research
  60. Towards Standardisation of a Diffuse Midline Glioma Patient-Derived Xenograft Mouse Model Based on Suspension Matrices for Preclinical Research
    Elvin ’t Hart, John I. Bianco, Helena C. Besse, Lois A. Chin Joe Kie, Lesley Cornet, Kimberly L. Eikelenboom, Thijs J M van den Broek, Marc P. P. Derieppe, Yan Su, Eelco Wieger Hoving et al. · 2023 · Biomedicines
  61. Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma
    Naohide Fujita, Andrew Bondoc, Sergio Simoes, Joji Ishida, Michael S. Taccone, Amanda J. Luck, Dilakshan Srikanthan, Robert Siddaway, Adrian Levine, Nesrin S Sabha et al. · 2024 · Brain Tumor Pathology
  62. Convergent epigenetic regulation of glial plasticity in myelin repair and brain tumorigenesis: A focus on histone modifying enzymes
    Jiajia Wang, Qing Richard Lu · 2020 · Neurobiology of Disease
  63. Enhancing Transcriptional Reprogramming of Mesenchymal Glioblastoma with Grainyhead-like 2 and HDAC Inhibitors Leads to Apoptosis and Cell-Cycle Dysregulation
    Spandana Kotian, Rachel M. Carnes, Josh Lewis Stern · 2023 · Genes
  64. Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies
    Julian S. Rechberger, Samantha M. Bouchal, Erica A. Power, Leo F. Nonnenbroich, Cody L. Nesvick, David J. Daniels · 2023 · Expert Opinion on Therapeutic Targets
  65. Preclinical Evaluation of panobinostat and ONC201 for the treatment of diffuse intrinsic pontine glioma (DIPG)
    Kaoutar Bentayebi, Keittisak Suwan, Azeddine Ibrahimi, Sara Louati, Mouna Ouadghiri, Tarik Aanniz, Saaïd Amzazi, Lahcen Belyamani, Amin Hajitou, Rachid Eljaoudi · 2023 · Brain Disorders
  66. Patrimonio cultural y patrimonio natural: ¿Una pareja imposible?
    María Ángeles Querol Fernández · 1995 · Extremadura arqueológica
  67. Brainstem Tumors
    Peter A. Chiarelli, Jason K. Chu, Mark D. Krieger · 2019 · Springer eBooks
  68. Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors
    Wenqiu Zhang, Ju‐Hee Oh, Wenjuan Zhang, Sneha Rathi, Jon D. Larson, Robert J. Wechsler‐Reya, Rachael W. Sirianni, William F. Elmquist · 2023 · Journal of Pharmacology and Experimental Therapeutics
  69. Whole-tumor histogram analysis of synthetic magnetic resonance imaging predicts isocitrate dehydrogenase mutation status in gliomas
    Xin Ge, Tiejun Gan, Zhihua Yang, Guangyao Liu, Wanjun Hu, Wenfu Ma, Yuping Bai, Yuhui Xiong, Min Li, Jianguo Zhao et al. · 2024 · Quantitative Imaging in Medicine and Surgery
  70. Neuroblastoma and Histone Demethylation
    Steven G. DuBois, Julie R. Park · 2018 · New England Journal of Medicine
  71. Fostering open collaboration in drug development for paediatric brain tumours
    Jong Fu Wong, Elizabeth Brown, Eleanor Williams, Alex N. Bullock · 2019 · Biochemical Society Transactions
  72. Genomic Biomarker Assessment in Gliomas
    Mary-Jane Lim-Fat, Lakshmi Nayak, David M. Meredith · 2020 · Surgical pathology clinics
  73. Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with PDGFR-α mutation: a case report
    Qiang Wang, Wenhao Niu, Hao Pan · 2021 · Acta Neurochirurgica
  74. Long-term survival of an infant with diffuse brainstem lesion diagnosed by prenatal MRI: a case report and review of the literature
    Maria Helena Suo-Palosaari, Heikki Rantala, Satu Lehtinen, Timo Kumpulainen, Niina Salokorpi · 2016 · Child s Nervous System
  75. Under explored epigenetic modulators: role in glioma chemotherapy
    Yanhong Chen, Wenjing Zeng, Zhipeng Wen, Quan Cheng, Xiaoping Chen · 2018 · European Journal of Pharmacology
  76. A primed immune transcriptional program is activated in oligodendroglia in multiple sclerosis
    Mandy Meijer, Eneritz Agirre, Mukund Kabbe, Cassandra A. van Tuijn, Abeer Heskol, Ana Mendanha Falcão, M. Ryan Corces, Thomas Jude Montine, Xingqi Chen, Howard Y. Chang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  77. A homogeneous treatment for non-DIPG diffuse midline glioma
    Elisabetta Schiavello, Veronica Biassoni, Giovanna Gattuso, Marta Giorgia Podda, Stefano Chiaravalli, Francesco Barretta, Manila Antonelli, Loris De Cecco, Emilia Pecori, Lorenza Gandola et al. · 2022 · Tumori Journal
  78. LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis
    Yuecheng Zeng, Zhenyu Yang, Yang Yang, Peng Wang · 2024 · Cell Division
  79. A biobank of patient derived glioma organoids
    Yulin Wen, Hongmin Bai, Qing Li, Sainan Huang, Xiaokun Jia, Guangjin Pan, Hongjie Yao · 2024 · Science China Life Sciences
  80. High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic
    Dannielle H. Upton, Jie Liu, Sandra M. George, Santosh Valvi, Caitlin Ung, Benjamin S. Rayner, Anjana Gopalakrishnan, Ruby Pandher, Aaminah Khan, Pooja Venkat et al. · 2025 · Neuro-Oncology
  81. Aberrant histone modifications in pediatric brain tumors
    Erin T. Hamanishi, Derek Dang, Sriram Venneti · 2025 · Frontiers in Oncology
  82. Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial
    Marie-Anne Debily, Gwénaël Le Teuff, Thomas Kergrohen, Pascale Varlet, David Castel, Pierre Leblond, Darren R. Hargrave, Karsten Nysom, Klas Blomgren, Geoffrey Brian McCowage et al. · 2026 · Nature Medicine
  83. Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
    Aran Merati, Spandana Kotian, Alexus Acton, William J. Placzek, Erin Smithberger, Abigail Shelton, C. Ryan Miller, Josh Lewis Stern · 2023 · International Journal of Molecular Sciences
  84. Radiotherapy plus temozolomide with or without anlotinib in H3K27M ‐mutant diffuse midline glioma: A retrospective cohort study
    Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong · 2024 · CNS Neuroscience & Therapeutics
  85. Differentiation therapy targeting the stalled epigenetic developmental programs in pediatric high-grade gliomas
    Wang Xiang, Xiaolin Zhang, Minhai Dong, Lijun Wan, Bin Zhang, Feng Wan · 2025 · Pharmacological Research
  86. H3F3A K27M mutations drive a repressive transcriptome by modulating chromatin accessibility independent of H3K27me3 in Diffuse Midline Glioma
    Suraj Bhattarai, Faruck Lukmanul Hakkim, Charles A. Day, Florina Grigore, Alyssa Langfald, Igor Entin, Edward H. Hinchcliffe, James P. Robinson · 2025 · Epigenetics & Chromatin
  87. Adult Diffuse Astrocytic and Oligodendroglial Tumors
    Catherine K. Gestrich, Marta Couce, Mark L. Cohen · 2021 · Neurosurgery
  88. The neurovascular unit in diffuse intrinsic pontine gliomas
    Fatma E. El‐Khouly, Rianne Haumann, Marjolein Breur, Sophie E. M. Veldhuijzen van Zanten, Gertjan J.L. Kaspers, N. Harry Hendrikse, Esther Hulleman, Dannis Gilbert van Vuurden, Marianna Bugiani · 2021 · Free Neuropathology
  89. Invited Review: The role and contribution of transcriptional enhancers in brain cancer
    Amir Arabzade, Austin J. Stuckert, Kelsey C. Bertrand, Stephen C. Mack · 2020 · Neuropathology and Applied Neurobiology
  90. Diffuse intrinsic pontine glioma: Insights into oncogenesis and opportunities for targeted therapy
    Andrew P. Groves, Pratiti Bandopadhayay, Tabitha M. Cooney · 2023 · Pediatric Hematology Oncology Journal
  91. Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma
    D. Johns, Richard J. Williams, Craig M. Smith, Pavani P. Nadaminti, Rasika M. Samarasinghe · 2024 · Clinical and Translational Medicine
  92. Diffuse Midline Glioma – Diffuse Intrinsic Pontine Glioma
    Mohammad Hassan A. Noureldine, Nir Shimony, George I. Jallo · 2020 · Springer eBooks
  93. Opportunities in the translational pipeline for pediatric brain cancer therapies
    Lindsay Rumberger Rivera, Nora L. Springer, Katherine M. Bailey, Jenny P. Patel, Christopher L. Brett, Elizabeth D. Barker · 2025 · Pediatric Research
  94. Feasibility of probe washing after stereotactic needle biopsy as a novel technique for developing cell lines and xenografts of H3 K27–altered diffuse midline gliomas
    Julian S. Rechberger, Liang Zhang, Jizhi Ge, Cody L. Nesvick, Kai Joshua Miller, David J. Daniels · 2023 · Journal of Neurosurgery Pediatrics
  95. Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy
    Sarasa Meenakshi, Krushna Ch Maharana, Lokesh Nama, Udaya Kumar Vadla, Sameer Dhingra, V. Ravichandiran, Krishna Murti, Nitesh Kumar · 2023 · Current Neuropharmacology
  96. A mathematical framework for analyzing drug combination toxicity for personalized medicine applications
    Raziur Rahman, Ranadip Pal · 2016 · IEEE Healthcare Innovations and Point of Care Technologies Conference (HI-POCT)
  97. Histone Lysine-to-Methionine Mutation as Anticancer Drug Target
    Jianhong Yang, Qiang Qiu, Lijuan Chen · 2020 · Advances in experimental medicine and biology
  98. Probabilistic Boolean Modeling of Pre‐clinical Tumor Models for Biomarker Identification in Cancer Drug Development
    Noah Berlow · 2021 · Current Protocols
  99. Histone H3 Variants in the Multiverse of Cancer
    Iva Simeonova, Geneviève Almouzni · 2024 · Annual Review of Cancer Biology
  100. The silent guardian: unraveling the roles of H3K9me3 in genome maintenance
    Zhiming Li, Zhiguo Zhang · 2024 · Genome Instability & Disease